Zoological pharmacology: current status, issues, and potential.

Area of Science:

• Veterinary Pharmacology
• Zoological Medicine

Background:

• Limited availability of approved pharmaceutical agents and pharmacokinetic data for exotic, wildlife, and zoo species presents a significant challenge for veterinarians.
• Practitioners often extrapolate drug use from approved veterinary or human agents to non-domestic species without substantial scientific evidence.
• Existing literature on pharmacokinetic parameters for drugs in non-domestic species is scarce, complicating treatment decisions.

Purpose of the Study:

• To review the current landscape of zoological pharmacology.
• To identify emerging trends and future directions in the field of drug therapy for zoo and wildlife species.

Main Methods:

• Literature review of existing studies on drug use and pharmacokinetics in exotic, wildlife, and zoo animals.
• Analysis of challenges faced by veterinarians in administering and selecting medications for non-domestic species.
• Discussion of the implications of limited data on treatment efficacy and animal welfare.

Main Results:

• Significant data gaps exist regarding drug efficacy, safety, and pharmacokinetic profiles in zoo and wildlife populations.
• Current practices often rely on extrapolation, leading to potential issues with patient compliance and treatment outcomes.
• The high value of these animals makes 'trial and error' approaches to drug selection and administration often inappropriate.

Conclusions:

• There is a critical need for more research into the pharmacology of drugs in non-domestic species.
• Developing evidence-based guidelines for drug use in zoological settings is essential for improving animal health and welfare.
• Advancements in zoological pharmacology are crucial for the future of exotic and wildlife animal care.